<DOC>
	<DOCNO>NCT00879710</DOCNO>
	<brief_summary>HMG CoA reductase inhibitor ( statin ) commonly use treat high cholesterol ( HC ) type 1 type 2 diabetes mellitus ( DM ) . Several study show benefit statin among patient type 2 DM , however , data available patient type 1 DM . It known study cholesterol metabolism use surrogate marker patient type 1 DM high cholesterol absorption compare normal type 2 DM high cholesterol synthesis . Since statin inhibit synthesis , patient type 1 DM may good response may respond good cholesterol absorption inhibitor . The purpose study determine cholesterol lower effect cholesterol absorption inhibitor cholesterol synthesis inhibitor subject type 1 type 2 diabetes mellitus .</brief_summary>
	<brief_title>Effect Diabetes Mellitus Cholesterol Metabolism</brief_title>
	<detailed_description>Hypothesis : 1 . Cholesterol absorption inhibitor like ezetimibe effective lower cholesterol subject type 1 diabetes mellitus . The primary outcome measure LDL cholesterol cholesterol tracer absorption . 2 . Cholesterol synthesis inhibitor like statin effective lower cholesterol subject type 2 diabetes mellitus . The primary outcome LDL cholesterol 24 Hour urinary mevalonic acid level . 3 . Response statin relate basal cholesterol synthesis rate . The primary outcome LDL cholesterol 24 Hour urinary mevalonic acid level . 4 . Response ezetimibe relate basal absorption rate . The primary outcome measure LDL cholesterol , phytosterol level cholesterol tracer absorption . Specific Aims : 1 . Measure baseline sterol absorption use plant sterol level synthesis use 24 h excretion urinary mevalonic acid level type 1 type 2 subject 2 . Measure change lipid parameter , cholesterol synthesis absorption marker type 1 type 2 subject 6 week therapy simvastatin 6 week therapy ezetimibe 4 week washout period 3 . Start collect blood future genetic analysis polymorphism cholesterol absorption gene Specific Methods : VISIT 1 : Evaluation subject willing participate study would carry GCRC require sample size recruit include follow : 1 . Sign inform consent 2 . Complete health questionnaire standardize format collect basic information regard past current medical history 3 . Physical exam include measurement blood pressure , height , weight , waist hip circumference perform . 4 . Blood ( 30ml ) would draw baseline chemistry include creatinine , ALT , CPK , fast lipid panel , Apo-B , Apo A1 , glycated hemoglobin ( HbA1c ) serum pregnancy test woman child bear age . Urine collect urine analysis presence protein urine 5 . Evaluation inclusion/exclusion criterion Subjects fulfil inclusion exclusion criterion would recruit study Following specific procedure follow : At start study , subject already lipid lower medication ask stop medication 4 week prior obtain baseline lab . No change make diet , exercise pattern treatment DM . This do telephone conversation . VISIT 2 ( Day 1 ) : Subjects report fast GCRC 8 AM . Subjects briefly meet bionutritionist 24 hour dietary recall instruction keep food diary day 2 3 . Blood sample ( 50ml ) collect fast glucose , insulin , lipid panel , Apo B , Apo A-1 , CPK , Hb A1c , plasma serum frozen sterol analysis ( GC ) WBC separate DNA extraction . The subject ask consume cholesterol tracer ( Cholesterol D5 ) . Subjects ask consume 8 ounce entirety . They ask eat/drink anything ( except water ) lunch time . If 8 Ounces inadequate breakfast , subject offer another 8 Oz serve Carnation® Instant Breakfast different flavor . If subject lactose intolerant , Lactaid tablets offer offset effect milk . If subject unable consume milk ( without Lactaid® ) allergic soy bean oil , ineligible participate study . Subjects send home urine jug collect 24-hour urine day 3 . VISIT 3 ( Day 4 ) : Subject bring urine jug food diary back analysis day blood ( 20ml ) collect evaluation tracer . Food diary review bionutritionist . Urine pregnancy test perform woman child bear age . Subjects start either simvastatin ezetimibe ( alternate subject half sample initially treat simvastatin half start ezetimibe ) . The dose Simvastatin ( Merck ) 40 mg orally nighttime 6 week dose ezetimibe ( Schering-Plough ) 10 mg take orally day . Subjects instruct low-fat diet ( therapeutic life style change diet ) recommend American Heart Association bionutritionist . VISIT 4 ( Day 46 ± 7 day ) : Subjects report fast GCRC 8 AM . The subject consume Carnation® Instant Breakfast cholesterol tracer ( Cholesterol D5 ) . Subjects ask maintain dietary restriction visit 2 . Subjects send home urine jug collect 24-hour urine day 3 . Subjects start food diary day 47 48 . VISIT 5 ( Day 49 ± 7 day ) : Subject bring urine jug food diary back analysis day blood ( 40ml ) collect evaluation tracer , lipid panel , Apo A1 , Apo B 100 , ALT , CPK , plasma serum store sterol analysis ( GC ) . Same day , weight , waist hip circumference measure . Food diary review bionutritionist . Subjects ask bring back pill bottle also pill count . Simvastatin ezetimibe stop 4 week . VISIT 6 ( Day 77 ± 7 day ) : Subjects ask come fasting GCRC 8 AM . 15ml blood collect measure lipid panel , apo B100 Apo A1 , Hb A1C , ALT level . Urine pregnancy test perform woman child bear age . Subjects start 10 mg ezetimibe 40 mg simvastatin mention next 6 week . VISIT 7 ( Day 119 ± 7 day ) : Subjects report fast GCRC 8 AM . The subject consume Carnation® Instant Breakfast cholesterol tracer ( Cholesterol D5 ) . Subjects ask maintain dietary restriction visit 2 . Subjects send home urine jug collect 24-hour urine day 3 . Subjects start food diary day 120 121 VISIT 8 ( Day 122 ± 7 day ) : Subject bring urine jug food diary back analysis day blood ( 40 ml ) collect evaluation tracer , lipid panel , Apo B100 , Apo A1 , Hb A1c , ALT , CPK , plasma serum store sterol analysis ( GC ) . Weight , waist hip circumference measure . Food diary review bionutritionist . Ezetimibe simvastatin therapy stop . Subjects ask resume usual cholesterol lower medication . Ending Study : Study end require participant enrol . We also consider stop study accumulate data suggests risk exceed benefit study preliminary data suggests clear advantage treat particular group certain agent .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Type 1 DM : Age &gt; 18 year Subjects diagnose type 1 DM ( diagnose base upon history ketoacidosis , proven insulin dependence , absent Cpeptide positive autoantibody profile ( antiGAD etc . ) Stable A1C &lt; 8.5 % BMI &lt; 31 Type 2 DM : Age &gt; 18 year Subjects diagnose type II DM ( diagnose adult onset , notinsulin dependent insulin ) Stable A1C &lt; 8.5 % BMI &lt; 31 History active , unstable cardiovascular disease ( include MI , CHF , Stroke , Angina , CABG , stenting/PTCA , peripheral vascular disease , intermittent claudication ) Pregnancy , nurse likely get pregnant course study ( oral contraceptive premenopausal ) Chronic Kidney Disease ( creatinine &gt; 2.0 ) Liver function test abnormality , previously work ( AST ALT &gt; 4x upper limit normal ) Active substance abuse include alcohol History severe Hypertriglyceridemia ( untreated TG &gt; 500 ) therapy Use agent interfere cholesterol absorption ( fiber , resins etc . ) discontinue duration study Actively enrol weight loss program follow special diet ( e.g . : Atkins diet ) History malignancy &lt; 5y History Rhabdomyolysis Myopathy Use ongoing oral corticosteroid History HIV infection Use follow drugs/compounds : cyclosporine , itraconazole , ketoconazole , erythromycin , clarithromycin , HIV protease inhibitor , nefazodone , gemfibrozil , niacin , amiodarone , verapamil large quantity grape fruit juice ( &gt; 1 quart per day ) Proteinuria : equal 300mg/24 hour calculate random urine specimen . BMI &gt; 31 Anyone hypersensitivity either one study medication Allergy Soy bean product Unable consume milk product without Lactaid®</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Simvastatin</keyword>
	<keyword>Ezetimibe .</keyword>
</DOC>